CD14

CD14

Target · Innate immune co-receptor

CD14 CD14 molecule · Monocyte differentiation antigen CD14

CD14 (monocyte differentiation antigen CD14, formerly CD14 antigen) is a surface antigen preferentially expressed on monocytes and macrophages. It acts as a coreceptor for bacterial lipopolysaccharide and helps drive the innate immune response. Browse Assay Genie's current range of CD14 research reagents below, or read on for the biology behind the target.

Cell membrane and secretedLPS coreceptorScavenger receptor group
375 aa
Protein length
~40 kDa
Molecular weight
5q31.3
Gene locus
CD molecule
Protein group
Target information

What is CD14 (CD14 molecule)?

CD14 is a coreceptor for bacterial lipopolysaccharide (LPS). Working in concert with LBP, it binds monomeric LPS and delivers it to the LY96/TLR4 complex, which mediates the innate immune response to LPS. Signalling proceeds via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response.

CD14 also acts as a coreceptor for Toll-like receptor 2 heterodimers. It supports the TLR2:TLR6 heterodimer in response to diacylated lipopeptides and the TLR2:TLR1 heterodimer in response to triacylated lipopeptides. These clusters trigger signalling from the cell surface and are then targeted to the Golgi in a lipid-raft dependent pathway. CD14 additionally binds electronegative LDL (LDL(-)) and mediates the cytokine release that LDL(-) induces.

The CD14 gene encodes a surface antigen preferentially expressed on monocytes and macrophages. According to NCBI Gene, it cooperates with other proteins in the innate response to bacterial LPS and to viruses, and alternative splicing yields multiple transcript variants that encode the same protein. UniProt records the protein at the cell membrane, in membrane rafts, in the Golgi apparatus and as a secreted form. HGNC places it among the CD molecules and scavenger receptors, and lists the previous name CD14 antigen. It has been identified as a target candidate for treating SARS-CoV-2-infected patients, with the aim of lessening or inhibiting a severe inflammatory response.

Innate immunity research

CD14 helps mediate the innate immune response to bacterial lipopolysaccharide and to viruses, making it central to studies of pathogen sensing.

Toll-like receptor signalling

CD14 delivers LPS to the LY96/TLR4 complex and acts as a coreceptor for TLR2:TLR1 and TLR2:TLR6 heterodimers.

Inflammation and cytokine release

Signalling via MyD88, TIRAP and TRAF6 leads to NF-kappa-B activation and cytokine secretion, a route studied in inflammatory responses.

Monocyte and macrophage biology

Preferential expression on monocytes and macrophages makes CD14 a surface antigen used to study these myeloid cells.

Background

CD14 frequently asked questions

What does CD14 do?

CD14 is a coreceptor for bacterial lipopolysaccharide. With LBP it binds monomeric LPS and delivers it to the LY96/TLR4 complex, triggering signalling through MyD88, TIRAP and TRAF6, NF-kappa-B activation and cytokine secretion. It also acts as a coreceptor for TLR2:TLR1 and TLR2:TLR6 heterodimers.

Does CD14 have other names or isoforms?

HGNC lists the gene as CD14 molecule, with the previous name CD14 antigen; UniProt calls the protein monocyte differentiation antigen CD14. NCBI Gene reports that alternative splicing produces multiple transcript variants, but all of them encode the same protein.

Is CD14 conserved and linked to disease?

Orthologues of the CD14 gene are annotated in mouse (Cd14) and rat (Cd14); check the datasheet of any product for its validated reactivity. NCBI Gene notes CD14 as a target candidate for SARS-CoV-2-infected patients, to potentially lessen a severe inflammatory response.

Explore

Related targets

Other CD molecules, myeloid markers and immune receptors with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P08571; product specifications from Assay Genie datasheets.

CD14 Product listing